NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Development Talks Medication Compliance

Benzinga 2022-11-07

Views 1

Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease.

Share This Video


Download

  
Report form
RELATED VIDEOS